Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Equilibration and Loading of Protein A Column – V 2.0

Posted on By


Biosimilars: SOP for Equilibration and Loading of Protein A Column – V 2.0


Standard Operating Procedure for Equilibration and Loading of Protein A Column in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/155/2025
Supersedes SOP/BS/155/2022
Page No. Page 1 of 10
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To describe the procedure for equilibrating and loading the Protein A chromatography column used for capture purification of monoclonal antibodies (mAbs) in biosimilar manufacturing under GMP conditions.

2. Scope

This SOP applies to all manufacturing batches involving Protein A capture chromatography using pre-packed or in-house packed columns in downstream processing facilities.

3. Responsibilities

  • Production: Execute equilibration and loading, monitor parameters, and record results.
  • QA: Review batch records and approve process execution.
  • Engineering: Ensure skid and pressure sensor functionality prior to use.

4. Accountability

The Downstream Production Manager is accountable for adherence to validated Protein A loading protocols and ensuring GMP compliance in documentation.

5. Procedure

5.1 Pre-Equilibration Checks

  1. Ensure the column has been properly sanitized and flushed as per SOP/BS/154/2025.
  2. Confirm the availability of equilibration buffer and that it has been filtered and labeled.
  3. Record buffer lot number, pH, and conductivity in Annexure-1: Equilibration and Loading Log.

5.2 Column Equilibration

  1. Connect the equilibration buffer line to the chromatography skid inlet.
  2. Prime the line and eliminate all air pockets.
  3. Set skid parameters:
    • Flow rate: 100–150 cm/hr
    • Volume: 5–10 column volumes (CV)
  4. Start buffer flow and monitor UV (280 nm), pH, and conductivity.
  5. Stabilize baseline (UV < 0.05 AU) before starting sample loading.

5.3 Loading of Product

  1. Connect harvest tank or depth-filtered clarified harvest to the skid product inlet.
  2. Ensure the harvest has passed pre-use bioburden and turbidity checks.
  3. Set skid:
    • Loading flow rate: 100–120 cm/hr
    • UV load limit: As defined in process validation or BMR (e.g., 70% DBC)
  4. Monitor:
    • Back pressure (must not exceed resin limit)
    • UV absorbance (to detect breakthrough)
  5. Terminate loading once breakthrough is detected or volume threshold is reached.

5.4 Column Wash (Optional)

  1. Pass 3–5 CV of wash buffer to remove weakly bound impurities (if part of validated protocol).
  2. Collect flowthrough in designated containers for analysis or discard.

5.5 Data Recording

  1. Record:
    • Buffer and sample volumes
    • Start/end times
    • Skid run ID
    • UV trend and batch comments
  2. Attach chromatogram printout and submit for QA review.

6. Abbreviations

  • CV: Column Volume
  • UV: Ultraviolet
  • DBC: Dynamic Binding Capacity
  • mAb: Monoclonal Antibody

7. Documents

  1. Equilibration and Loading Log – Annexure-1
  2. Buffer Preparation Record – Annexure-2

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO TRS 999 – Guidelines on Biotherapeutic Products
  • Protein A OEM Technical Manual – Cytiva / Repligen

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Equilibration and Loading Log

Date Batch No. Buffer Lot Flow Rate UV at Load Column ID Operator
04/05/2025 BS-DP-083 PBS-BL-05 125 cm/hr 0.54 AU PA-01 Ajay Verma

Annexure-2: Buffer Preparation Record

Buffer Name pH Conductivity Prepared By Lot No. Date
Equilibration Buffer 7.2 14.2 mS/cm Sunita Reddy PBS-BL-05 03/05/2025

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added UV monitoring step and breakthrough handling Operational improvement
See also  Biosimilars: SOP for Hydrophobic Interaction Chromatography - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Step-by-Step Guide to SOP Development in Pharma
Next Post: Gel Manufacturing: SOP for Maintaining Equipment Cleaning Logs – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version